HongShan logo

HongShan

Asia, Beijing, China, Beijing

Description

HongShan, formerly known as Sequoia China, is a preeminent venture capital firm based in Beijing, China, that officially rebranded in June 2023. This strategic separation from the global Sequoia network marked a new chapter for the firm, allowing it to operate independently while maintaining its deep roots and extensive network within the Chinese market. Building on a legacy of identifying and nurturing groundbreaking companies, HongShan continues to be a pivotal player in China's innovation ecosystem, deploying capital across various stages from seed to late-stage and growth investments.

The firm's investment strategy is comprehensive, targeting a broad spectrum of high-growth sectors beyond just fintech, including technology, consumer, healthcare, and industrial technology. HongShan leverages its profound local market understanding and operational expertise to support its portfolio companies, helping them scale rapidly and achieve market leadership. Its approach is characterized by a long-term perspective, often providing not just capital but also strategic guidance, talent acquisition support, and access to a vast network of industry leaders and partners.

With an impressive track record, HongShan has been instrumental in backing some of China's most successful enterprises. In 2022, the firm reportedly raised approximately $9 billion across four new funds, underscoring its significant financial capacity and investor confidence. Since its inception in 2005, the firm has invested in over 1,200 companies, many of which have gone on to achieve significant valuations, including numerous IPOs and successful exits. This extensive portfolio and consistent ability to identify future market leaders solidify HongShan's position as a dominant force in the Asian venture capital landscape.

Investor Profile

HongShan has backed more than 354 startups, with 36 new investments in the last 12 months alone. The firm has led 136 rounds, about 38% of its total and boasts 108 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Singapore.
  • Strong thematic focus on Biotechnology, Artificial Intelligence (AI), E-Commerce.
  • Led 15 rounds in the past year.
  • Typical check size: $1M – $150M.

Stage Focus

  • Series B (25%)
  • Series A (22%)
  • Series C (16%)
  • Seed (10%)
  • Series D (9%)
  • Series Unknown (5%)
  • Series E (4%)
  • Series F (3%)
  • Private Equity (2%)
  • Angel (2%)

Country Focus

  • China (66%)
  • United States (10%)
  • Singapore (6%)
  • Hong Kong (4%)
  • Australia (4%)
  • South Korea (2%)
  • France (1%)
  • Nigeria (1%)
  • Japan (1%)
  • Switzerland (1%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • E-commerce
  • Software
  • Health Care
  • Internet
  • Information Technology
  • Financial Services
  • Medical
  • Apps
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HongShan frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 30
ZhenFund
Asia, Beijing, China, Beijing
Co-Investments: 15
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 20
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 24
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 33
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 30
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 16
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 21
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 14
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 36

Which angels does HongShan often collaborate with?

Michael van Paesschen
Asia, Singapore
Shared Deals: 1
Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
AS
North America, California, United States, San Francisco
Shared Deals: 1
WM
North America, New York, United States, New York
Shared Deals: 2
JS
North America, California, United States, San Francisco
Shared Deals: 1
Adrian Cheng
Asia, Hong Kong
Shared Deals: 2
JM
North America, California, United States, Los Angeles
Shared Deals: 1
Shared Deals: 1
Ahmed Al-Balaghi
Asia, United Arab Emirates
Shared Deals: 1
Aniket Jindal
Asia, Delhi, India
Shared Deals: 1

What are some of recent deals done by HongShan?

Yunzhou Zhiwei

Wuhan, Hubei, China

Yunzhou Zhiwei is a large-scale equipment maintenance service provider.

AerospaceConsumer
SeedAug 22, 2025
Midas

Üsküdar, Istanbul, Turkey

Midas is a regulated brokerage firm that offers investment services for equities, mutual funds, and cryptocurrencies.

AppsCryptocurrencyFinancial ServicesFinTechTrading Platform
Series BAug 19, 2025
Amount Raised: $80,000,000
Eight Sleep

New York, New York, United States

Eight Sleep develops a smart sleep system that dynamically adjusts temperature, elevation, and sound.

Consumer ElectronicsHealth CareWellness
Series DAug 19, 2025
Amount Raised: $100,000,000
Xunlu Innovation

Shenzhen, Guangdong, China

Xunlu Innovatiom is the bicycle manufacturers

AutomotiveManufacturing
Series AAug 8, 2025
OpenMind

San Francisco, California, United States

OpenMind is a software company that develops an operating system for robots and intelligent machines.

Artificial Intelligence (AI)RoboticsSoftware
Series AAug 4, 2025
Amount Raised: $20,000,000
Excalipoint Therapetics

Admiralty, Hong Kong Island, Hong Kong

Excalipoint Therapeutics is a Private limited company.

Therapeutics
Series AAug 4, 2025
Amount Raised: $41,000,000

Creao AI a provider of AI-powered agent automation and virtual environments.

Artificial Intelligence (AI)
SeedJul 31, 2025
RD Technologies

Hong Kong, Hong Kong Island, Hong Kong

Trusted Multi-currency Business Account for Global Businesses

FinanceFinTechPayments
Series AJul 30, 2025
Amount Raised: $40,000,000
Tongxin Medical Equipment

Suzhou, Jiangsu, China

Tongxin Medical Equipment is an artificial-heart maker company.

Biotechnology
Series UnknownJul 21, 2025
Amount Raised: $100,000,000
Xinyanyi Code

Shenzhen, Guangdong, China

Xinyanyi Code is an artificial intelligence programming application service provider.

Series UnknownJul 1, 2025